In this webinar, our speakers talk about how newborn screening (NBS) has helped the rare disease community and the potential for closer partnership in clinical trials. Topics will include:
• History and purpose of NBS in the US and globally
• Diagnostic journey for rare disease patients and the role of NBS
• NBS public policy
• Challenges and limitations of screening programs and addition of more panels
• Advocacy efforts for NBS
• Why NBS is important for enrollment of rare disease clinical trials
Authors:
Derek Ansel
Executive Director, Therapeutic Strategy Lead, Rare Diseases
